Vaccinations

AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official

Tue, 2021-02-23 18:49 — mike kraft

Exclusive: AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official AstraZeneca expects to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter, an EU official told Reuters on Tuesday. Francesco Guarascio U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official
Log in or register to post comments

Drug executives testify that big jump in vaccine supply is coming soon

Tue, 2021-02-23 18:39 — mike kraft

Drug executives: Big jump in vaccine supply is coming soon

WASHINGTON (AP) — COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most Americans to get inoculated by summer.

By the end of March, Pfizer and Moderna expect to have provided the U.S. government with a total of 220 million vaccine doses, up sharply from the roughly 75 million shipped so far.

“We do believe we’re on track,” Moderna President Stephen Hoge said, outlining ways the company has ramped up production. “We think we’re at a very good spot.”

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Drug executives testify that big jump in vaccine supply is coming soon
Log in or register to post comments

Institutional investors urge a more ‘fair and equitable’ international Covid-19 response

Tue, 2021-02-23 11:22 — mike kraft

Dozens of institutional investors push for 'equitable' Covid-19 response “The economic and financial damage triggered by Covid-19 knows no border,” said Marco Morelli, executive chairman of AXA Investment Managers. Ed Silverman STAT

Nearly 150 institutional investors that oversee combined assets worth more than $14 trillion have issued a joint call for a “fair and equitable” global response to the Covid-19 pandemic, and they intend to huddle with health care companies to make progress on that goal.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Institutional investors urge a more ‘fair and equitable’ international Covid-19 response
Log in or register to post comments

False claims that coronavirus vaccines can cause infertility drive doubts among women of childbearing age

Tue, 2021-02-23 10:58 — mike kraft

False claims tying coronavirus vaccines to infertility drive doubts among women of childbearing age Health officials worry their hesitation may affect efforts to reach immunization targets. Ariana Eunjung Cha Washington Post

As the rollout of the coronavirus vaccine ramps up across the United States, women of childbearing age have emerged as a surprising roadblock to efforts to halt the pandemic by achieving herd immunity.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

OVERVIEW: U.S. and International

Tue, 2021-02-23 10:39 — mike kraft

U.S and international COVID-related developments

ALSO SEE: Reuters worldwide roundup

SACRAMENTO, Calif. -- California lawmakers have cleared the way for 5.7 million people to get at least $600 in one-time payments, part of a state-sized coronavirus relief package aimed at helping lower-income people weather what they hope is the last legs of the pandemic.

The state Legislature passed the bill by a wide margin on Monday...

BUDAPEST — Officials in Hungary are urging people to trust in the vaccines already approved by the country ahead of a planned rollout Wednesday of a COVID-19 vaccine developed in China.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: U.S. and International
Log in or register to post comments

240 million vaccine doses expected for the US by end of March --Pharm company testimony

Tue, 2021-02-23 10:14 — mike kraft

Pharmaceutical companies pledge 240 million vaccine doses for the US by end of March The United States can expect to see a total of 240 million doses of Covid-19 vaccine by the end of March, according to prepared remarks drug companies will deliver to a House subcommittee today. The vaccine makers are set to testify at 10:30 a.m. ET. By <a href="/profiles/helen-regan">Helen Regan</a>, Eoin McSweeney and Ed Upright, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about 240 million vaccine doses expected for the US by end of March --Pharm company testimony
Log in or register to post comments

FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing

Tue, 2021-02-23 10:04 — mike kraft

The Food and Drug Administration said on Monday that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants.

The recommendations, which call for small trials more like those required for annual flu vaccines, would greatly accelerate the review process at a time when scientists are increasingly anxious about how the variants might slow or reverse progress made against the virus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing
Log in or register to post comments

TheHill.com Johnson & Johnson ready to provide doses for 20M Americans by end of March

Mon, 2021-02-22 20:14 — mike kraft

Johnson & Johnson ready to provide doses for 20M Americans by end of Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration. Peter Sullivan TheHill

Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about TheHill.com Johnson & Johnson ready to provide doses for 20M Americans by end of March
Log in or register to post comments

Differences between COVID-19 vaccines, summarized in a simple table

Mon, 2021-02-22 20:02 — mike kraft

All the differences between COVID-19 vaccines, summarized in a simple table that you can take to your vaccination appointment This summary table shows the differences among the COVID-19 vaccines from Pfizer-BioNTech, Moderna, and AstraZeneca-Oxford University. Dr. Catherine Schuster-Bruce Business Insider

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Differences between COVID-19 vaccines, summarized in a simple table
Log in or register to post comments

British data study says COVID-19 vaccines sharply cut hospitalizations

Mon, 2021-02-22 18:11 — mike kraft

LONDON (AP) — Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.

Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COVID-19 by 70% after one dose, a figure that rose to 85% after the second.

“This new evidence shows that the jab protects you, and protects those around you,” U.K. Health Secretary Matt Hancock said. “It is important that we see as much evidence as possible on the vaccine’s impact on protection and on transmission and we will continue to publish evidence as we gather it.’’

Country / Region Tags:

General Topic Tags: